Imunon Inc reports results for the quarter ended in December - Earnings Summary

Imunon

28/03/2024 13:31

* Imunon Inc  IMNN.OQ  reported a quarterly adjusted loss
of 52
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of
$-1.61.  The mean expectation of two analysts for the quarter
was for a loss of 41 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * Imunon Inc's reported EPS for the quarter was a loss of 52
cents​.
    * The company reported a quarterly loss of $4.89 million.
    * Imunon Inc shares had risen by 105.9% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 28.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Imunon Inc is
$12.00 
This summary was machine generated from LSEG data March 28 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.41          -0.52          Missed
 Sep. 30 2023      -0.66          -0.37          Beat
 Jun. 30 2023      -0.70          -0.61          Beat
 Mar. 31 2023      -0.66          -0.68          Missed